Corporate News 26-Jun-23
Ajanta Pharma's Dahej unit clears USFDA audit
Ajanta Pharma announced that the company's formulation facility at Dahej was inspected by US FDA from 19 June 2023 to 23 June 2023. At the end of inspection, no Form 483 was issued to the company.
Previous News
Ajanta Pharma fixes record date for interim dividend
( Market Beat - Reports 28-Jul-23 12:34 )
Ajanta Pharma
( Results - Analysis 01-Feb-23 17:14 )
Board of Ajanta Pharma recommends First Interim Dividend
( Corporate News - 28-Jul-23 10:22 )
Ajanta Pharma to hold board meeting
( Corporate News - 15-Jul-23 10:48 )
Ajanta Pharma consolidated net profit declines 5.05% in the March 2022 quarter
( Results - Announcements 10-May-22 14:37 )
Ajanta Pharma
( Results - Analysis 31-Jan-22 17:21 )
Neuland Laboratories Ltd Spurts 8.97%, S&P BSE Healthcare index Rises 1.07%
( Hot Pursuit - 03-Feb-21 09:30 )
Volumes soar at Syngene International Ltd counter
( Hot Pursuit - 28-Jul-23 11:00 )
Ajanta Pharma Q1 FY22 PAT grows 18% to Rs 174 cr
( Hot Pursuit - 30-Jul-21 09:30 )
Ajanta Pharma standalone net profit declines 3.74% in the December 2017 quarter
( Results - Announcements 25-Jan-18 17:11 )
Volumes spurt at K E C International Ltd counter
( Hot Pursuit - 13-Sep-23 11:00 )
Other Stories
GAIL (India) signs MoU with AM Green
04-Oct-24 19:27
EaseMyTrip.com resumes bookings to the Maldives
04-Oct-24 19:25
BLS completes acquisition of Dubai-based Citizenship Invest
04-Oct-24 19:23
Insecticides India launches new maize herbicide 'Torry Super'
04-Oct-24 19:21
Landmark Cars receives LoI from Mercedes-Benz India
04-Oct-24 19:19
Astra Microwave Products receives affirmation in credit ratings from CRISIL
04-Oct-24 19:16
Supreme Petrochem receives affirmation in credit ratings
04-Oct-24 19:10
Astec LifeSciences director resigns
04-Oct-24 19:08
Board of Gravita India approves change in directorate
04-Oct-24 19:05
Board of Gravita India approves fund raising up to Rs 1,000 cr
04-Oct-24 19:03
Back
Top
